The partnership between Varian Medicinal Systems and The Danish Capital Region is one of many public-private partnerships initiated in Denmark in recent years.
In Varian’s case, a large research contract is part of the agreement, allowing Varian and the involved hospitals to improve upon existing technologies and quickly implement new technologies into clinical operation. Considering the large talent pool in Denmark of qualified researchers and scientists, such an agreement can only help improve upon current projects and boost the development of new technologies.
Public-private partnerships in Denmark add immense value to all parties involved. As seen in the Varian case, the Danish healthcare system massively benefits when it can attract the newest technology from the private sector. Meanwhile, the company gains access to a perfect showcase market, with a strong cooperative culture between industry players, universities, and hospitals.